Importantly, the liver transcriptome signature in ob/ob-NASH mice receiving combined OCA and ELA treatment supports the histological outcomes by indices of improved lipid handling and insulin signaling with concurrent attenuation of both immune and pro-fibrotic gene expression patterns. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.